Fundraising Fox
Healthspan Capital
Venture capitalOxford · Seed–Series A · 1 people tracked
Find your way into Healthspan Capital
Sign up to see every warm intro you have to Healthspan Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Healthspan Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Healthspan Capital invests in a diversified portfolio of early-stage longevity biotechnology companies developing novel approaches to address aging, disease, and human lifespan. The fund leverages deep expertise in longevity biotech company creation and investment, backed by an extensive network of collaborators, advisors, and founders in the space. The rolling fund structure provides simple and flexible access for investors to participate in the longevity biotech sector.
Source: firm website, verified Aug 6, 2026.
Team · 1 people
from public directories
What they invest in
from 4 of 5 portfolio companiesBiotech ×4Healthtech ×4Deep Tech ×3AI & Machine Learning ×2Longevity ×1Medical Devices ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22023 · 12021 · 15 dated
Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.
AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US
Linda Goodman(Founder)inAshley(CEO)
Co-investorsage1Farvatn VentureGaingelsGRIDS CapitalLifeforce CapitalLifespan Vision Ventures+8 more
__Twitter.png)
ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Peretz Partensky(Executive Officer, Director)inStuart Alexander Jacobson(Executive Officer, Director)Nina Horowitz(Chief Executive Officer)inRui Tostoes(Chief Technology Officer)inAlicia Jackson(Director)in
BoardDylan Morris(Director)in
Co-investorsGaingelsLong GameM VenturesNFXPioneerInsight Partners+2 more
Modulate Bio develops small-molecule GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.
BiotechDeep TechHealthtechAllston, US
Dario Doller(Co-founder)inKevin Hodgetts(Founding Lab / Co-founder)inAndrew Thomson(Executive Officer, Director, Promoter)in
Co-investorsPillar VCPalo Santo VC
Oisín Biotechnologies develops non-viral genetic therapies built on its Fusogenix Proteo-Lipid Vehicle (PLV) delivery platform, which delivers DNA and RNA payloads to tissues throughout the body and allows repeat dosing.
BiotechHealthtechLongevitySeattle, US
Matthew Scholz(Executive Officer, Director)inEric Garcia(Executive Officer)inStephen Hilbert(Executive Officer)John Lewis(Executive Officer)inGary Hudson(Executive Officer, Director)in
BoardDavid Gobel(Director)
Co-investorsIKJ CapitalLong GameMethuselah Funds
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Jung+ Longevity
Portfolio news
latest coverage across their companies
Oisin Biotechnologies · futuresearch.ai · Jul 3, 2026
Frequently asked questions
- How many investments has Healthspan Capital made?
- Healthspan Capital has 5 tracked investments, including 3 dated in the last 24 months.
- What stage does Healthspan Capital invest at?
- Healthspan Capital invests at the Seed, Series A stages.
- What is Healthspan Capital's typical check size?
- Healthspan Capital typically writes checks of $5K.
- What sectors does Healthspan Capital focus on?
- Healthspan Capital focuses on Biotech, Longevity.
- Where is Healthspan Capital located?
- Healthspan Capital is headquartered in Oxford, GB.
Media · Podcasts & interviews
featuring the teamSebastian Brunemeier, Partner at HealthSpan Capital talks to IBTV at Advanced Therapies Europe 2024
IBTV · Sebastian Brunemeier
Similar investors
Boundary Capital is a UK-based impact investment fund that backs high-growth early-stage private technology companies in sectors such as life sciences, AI and engineering, offering tax-efficient investment opportunities through an HMRC Knowledge Intensive Approved Fund.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.